Cargando…
Albumin-bound formulation of paclitaxel (Abraxane(®) ABI-007) in the treatment of breast cancer
Breast cancer is the most common type of malignancy diagnosed in women. In the metastatic setting this disease is still uncurable. Taxanes represent an important class of antitumor agents which have proven to be fundamental in the treatment of advanced and early-stage breast cancer, but the clinical...
Autores principales: | Miele, Evelina, Spinelli, Gian Paolo, Miele, Ermanno, Tomao, Federica, Tomao, Silverio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720743/ https://www.ncbi.nlm.nih.gov/pubmed/19516888 |
Ejemplares similares
-
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
por: Miele, Evelina, et al.
Publicado: (2012) -
Breast cancer metastatic to the pituitary gland: a case report
por: Spinelli, Gian Paolo, et al.
Publicado: (2012) -
Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008) -
nab-Paclitaxel (Abraxane(®)): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors
por: Iglesias, J
Publicado: (2009) -
A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
por: Tomao, Silverio, et al.
Publicado: (2006)